Hypertension, blood pressure variability, and target organ lesion

MC Irigoyen, K De Angelis, F Dos Santos… - Current hypertension …, 2016 - Springer
Hypertensive patients have a higher risk of developing health complications, particularly
cardiovascular (CV) events, than individuals with normal blood pressure (BP). Severity of …

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence

C Antza, S Stabouli, V Kotsis - Vascular health and risk …, 2016 - Taylor & Francis
Hypertension is an important risk factor for premature death as it increases the probability of
stroke, myocardial infarction, and heart failure. Antihypertensive drugs can decrease …

New Insights into the Nephroprotective Potential of Lercanidipine

J Hajdys, P Fularski, K Leszto, G Majchrowicz… - International Journal of …, 2023 - mdpi.com
Kidneys are responsible for many crucial biological processes in the human body, including
maintaining the water–electrolyte balance, pH, and blood pressure (BP), along with the …

Effects of percutaneous transluminal renal angioplasty on office and home blood pressure and home blood pressure variability in hypertensive patients with renal …

Y Iwashima, T Fukuda, H Kusunoki, S Hayashi… - …, 2017 - Am Heart Assoc
This study included 126 hypertensive patients with renal artery stenosis (mean age, 63
years; 22.2% fibromuscular dysplasia [FMD]) and investigated the effects of percutaneous …

Leki złożone w terapii nadciśnienia tętniczego w Polsce Stanowisko Ekspertów Polskiego Towarzystwa Nadciśnienia Tętniczego oraz Sekcji Farmakoterapii Sercowo …

A Tykarski, K Widecka, K Narkiewicz… - arterial …, 2017 - journals.viamedica.pl
Nadciśnienie tętnicze jest podstawowym modyfikowalnym czynnikiem ryzyka chorób
sercowo-naczyniowych: choroby niedokrwiennej serca, udaru mózgu, niewydolności serca i …

The level of pancreatic fecal elastase-1 and the risk of cardiovascular complications in patients with chronic pancreatitis combined with arterial hypertension

AY Filippova, VV Kryvoshei - Gastroenterology, 2023 - gastro.zaslavsky.com.ua
Background. Chronic pancreatitis and malnutrition are associated with cardiovascular
diseases and cardiovascular events, while the role of exocrine pancreatic insufficiency as a …

Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non …

C Tsioufis, K Dimitriadis, E Mantzouranis… - Current Medical …, 2016 - Taylor & Francis
Objective: The aim of the present study was to compare the effects of the combination of
lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on …

C-reactive protein and blood pressure variability in type 2 hypertensive diabetic patients

ASO Schein, PM Bock, D Massierer, M Gus… - Blood Pressure …, 2019 - journals.lww.com
Objective Increased blood pressure (BP) variability and inflammation are included among
the factors recognized as potential predictors of cardiovascular events in type 2 diabetes …

Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish …

A Tykarski, K Widecka, K Narkiewicz… - Polish Heart …, 2017 - journals.viamedica.pl
The reasons for the publication of current expert consensus statement after 4 years from the
previous one are: the growing number of evidence on the benefits of the use of single-pill …

Current perspective on the use of calcium channel blockers to treat hypertensive patients: the role of lercanidipine

G Mancia, K Tsioufis - 2019 - Taylor & Francis
The symposium 'Current perspective on the use of calcium channel blockers in the treatment
of hypertensive patients', held in Stresa (Italy) on 28th and 29th June 2018 with the …